SPRINT PNS System
Device
SPR Therapeutics, Inc
Total Payments
$12.7M
Transactions
23,885
Doctors
7,826
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2.8M | 8,508 | 3,734 |
| 2023 | $3.5M | 7,221 | 3,166 |
| 2022 | $1.9M | 4,155 | 2,240 |
| 2021 | $1.4M | 1,544 | 958 |
| 2020 | $1.1M | 798 | 496 |
| 2019 | $1.1M | 1,119 | 677 |
| 2018 | $501,481 | 486 | 315 |
| 2017 | $375,799 | 54 | 40 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8.3M | 603 | 65.7% |
| Consulting Fee | $2.4M | 641 | 18.5% |
| Food and Beverage | $1.3M | 21,375 | 10.6% |
| Travel and Lodging | $655,718 | 1,264 | 5.2% |
| Charitable Contribution | $4,900 | 1 | 0.0% |
| Honoraria | $2,800 | 1 | 0.0% |
Payments by Type
Research
$8.3M
603 transactions
General
$4.4M
23,282 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain | SPR Therapeutics, Inc | $3.2M | 0 |
| A Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain | SPR Therapeutics, Inc | $925,968 | 0 |
| Treatment of Post-Operative Pain Following Orthopedic Surgery with SPRINT Peripheral Nerve Stimulation (PNS) System in a Randomized, Double-Blinded, Placebo-Controlled Trial | SPR Therapeutics, Inc | $764,870 | 0 |
| The SNAP Trial: SPRINT peripheral nerve stimulation for the treatment of Neuropathic post-Amputation Pain in a randomized, double-blinded, placebo-controlled, multicenter trial | SPR Therapeutics, Inc | $687,892 | 0 |
| A Prospective Case Series Study of SPR peripheral nerve stimulation (PNS) therapy for the treatment of pain following total knee arthroplasty (TKA) utilizing preoperative lead placement | SPR Therapeutics, Inc | $472,537 | 0 |
| Treatment of Post-Operative Pain Following Orthopedic Surgery with SPRINT Peripheral Nerve Stimulation (PNS) System in a Randomized, Double-blind, Placebo-Controlled Trial | SPR Therapeutics, Inc | $389,675 | 0 |
| The MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Case Series Study: Treatment of Head Pain with the SPRINT Peripheral Nerve Stimulation | SPR Therapeutics, Inc | $354,486 | 0 |
| Treatment of head pain with the SPRINT Peripheral Nerve Stimulation (PNS) System | SPR Therapeutics, Inc | $278,635 | 0 |
| A Prospective Case Series Study of SPR peripheral nerve stimulation PNS therapy for the treatment of pain following total knee arthroplasty TKA utilizing preoperative lead placement | SPR Therapeutics, Inc | $215,124 | 0 |
| The SNAP Trial SPRINT peripheral nerve stimulation for the treatment of Neuropathic post Amputation Pain in a randomized double blinded placebo controlled multicenter trial | SPR Therapeutics, Inc | $202,890 | 0 |
| Ilfeld DOD Phase 1 | SPR Therapeutics, Inc | $135,224 | 0 |
| Retrospective Review of the SPRINT PNS System for the Treatment of Chronic Shoulder Pain | SPR Therapeutics, Inc | $115,635 | 0 |
| A Randomized, Double-Blinded, Placebo-Controlled, Multicenter Pilot Study of the SPRINT Peripheral Nerve Stimulation (PNS) System for the Treatment of Post-Amputation Pain | SPR Therapeutics, Inc | $84,750 | 0 |
| A Randomized Double Blinded Placebo Controlled Multicenter Pilot Study of the SPRINT Peripheral Nerve Stimulation (PNS) System for the Treatment of Post Amputation Pain | SPR Therapeutics, Inc | $74,518 | 0 |
| A randomized double blinded placebo controlled multicenter pilot study of the SPRINT PNS System for the treatment of post amputation pain | SPR Therapeutics, Inc | $70,524 | 0 |
| Percutaneous Peripheral Neuromodulation for Post-operative Analgesia | SPR Therapeutics, Inc | $62,382 | 0 |
| The SNAP Trial: SPRINT peripheral nerve stimulation for the treatment of Neuropathic post-Amputation Pain in a randomized, double-blind, placebo-controlled, multicenter trial | SPR Therapeutics, Inc | $56,850 | 0 |
| PNS for SIS 1RO1HD093661-01A1 | SPR Therapeutics, Inc | $44,401 | 0 |
| Multi-Modal Treatment for HSP RO1HD084564 | SPR Therapeutics, Inc | $41,853 | 0 |
| A Pilot Study of Return Electrode Configuration of SPRINT Percutaneous Peripheral Nerve Stimulation (PNS) | SPR Therapeutics, Inc | $41,260 | 0 |
Top Doctors Receiving Payments for SPRINT PNS System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Silver Spring, MD | $8.3M | 603 |
| , MD | Pain Medicine | New York, NY | $291,604 | 191 |
| , MD | Pain Medicine | Winston Salem, NC | $252,361 | 188 |
| , MD | Anesthesiology | Boston, MA | $145,816 | 128 |
| , D.O | Pain Medicine | Germantown, MD | $142,487 | 163 |
| , M.D | Physical Medicine & Rehabilitation | Boston, MA | $138,209 | 155 |
| , M.D | Pain Medicine | Pasadena, CA | $129,917 | 78 |
| , D.O | Pain Medicine | New York, NY | $119,451 | 102 |
| , M.D | Pain Medicine | Shrewsbury, NJ | $105,094 | 103 |
| , M.D | Anesthesiology | New York, NY | $103,707 | 107 |
| , MD | Pain Medicine | Stanford, CA | $98,766 | 85 |
| , MD | Anesthesiology | Roseville, CA | $95,490 | 129 |
| , M.D | Anesthesiology | San Diego, CA | $94,030 | 126 |
| , M.D | Anesthesiology | Skokie, IL | $93,854 | 123 |
| , M.D | Interventional Pain Medicine | Oshkosh, WI | $90,771 | 176 |
| , M.D | Anesthesiology | Baltimore, MD | $83,963 | 27 |
| , M.D | Anesthesiology | Redwood City, CA | $72,795 | 78 |
| , M.D | Pain Medicine | New Haven, CT | $69,444 | 129 |
| , M.D., D.ABA | Pain Medicine | Detroit, MI | $69,100 | 83 |
| Alaa Abd-Elsayed | Pain Medicine | Madison, WI | $65,725 | 67 |
| , M.D | Pain Medicine | Austin, TX | $60,466 | 116 |
| , M.D | Anesthesiology | Chicago, IL | $58,966 | 97 |
| , MD | Anesthesiology | Kent, OH | $57,755 | 48 |
| , M.D | Anesthesiology | Rochester Hills, MI | $51,985 | 64 |
| , M.D | Pain Medicine | Los Angeles, CA | $48,915 | 56 |
Ad
Manufacturing Companies
- SPR Therapeutics, Inc $12.7M
Product Information
- Type Device
- Total Payments $12.7M
- Total Doctors 7,826
- Transactions 23,885
About SPRINT PNS System
SPRINT PNS System is a device associated with $12.7M in payments to 7,826 healthcare providers, recorded across 23,885 transactions in the CMS Open Payments database. The primary manufacturer is SPR Therapeutics, Inc.
Payment data is available from 2017 to 2024. In 2024, $2.8M was paid across 8,508 transactions to 3,734 doctors.
The most common payment nature for SPRINT PNS System is "Unspecified" ($8.3M, 65.7% of total).
SPRINT PNS System is associated with 20 research studies, including "A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain" ($3.2M).